Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.
Journal: bioRxiv : the preprint server for biology
Published: September 29, 2025
Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.
Journal: Brain : a journal of neurology
Published: September 10, 2025
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.
Journal: Molecular cancer therapeutics
Published: August 22, 2025
Incidence and Survival of IDH-Wildtype Glioblastoma and IDH-Mutant Astrocytoma by Treatment and Sex: A Regional Study in Spain (2011-2021).
Journal: Medical sciences (Basel, Switzerland)
Published: July 28, 2025
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer.
Journal: NPJ breast cancer
Published: September 17, 2024
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.
Journal: Nature
Published: April 03, 2024
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.
Journal: Science signaling
Published: February 27, 2024
The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtype.
Journal: Neuro-oncology advances
Published: October 27, 2023
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.
Journal: British journal of cancer
Published: September 25, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
Journal: NPJ breast cancer
Published: September 19, 2023
Last Updated: 09/26/2026